This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Atilla PA, et al. Hepatitis B reactivation rate and fate among multiple myeloma patients receiving regimens containing lenalidomide and/or bortezomib. Turkish Journal of Hematology 36: 266-273, No. 4, Dec 2019. Available from: URL: http://doi.org/10.4274/tjh.galenos.2019.2019.0103